Genprex stock tumbles after announcing $3.4 million registered offering By Investing.com
Update: 2025-10-29
Description
Genprex, a clinical-stage gene therapy company, announced a fundraising move that saw its stock drop by over twenty percent. The company is raising $3.4 million by selling shares at $9 each and offering short-term warrants for an additional $6.6 million. The funds will be used to support ongoing research in gene therapies for cancer and diabetes.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
